Anti-SSR4 monoclonal antibody

Pre-made anti-SSR4 monoclonal antibody(mab)-benchmark antibody for ELISA, affinity binding assay, drug discovery and mechanism of action (MOA) research

Target products collectionGo to SSR4/SSR4 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-IP1827-Ab-1/ GM-Tg-hg-IP1827-Ab-2Anti-Human SSR4 monoclonal antibodyHuman
GM-Tg-rg-IP1827-Ab-1/ GM-Tg-rg-IP1827-Ab-2Anti-Rat SSR4 monoclonal antibodyRat
GM-Tg-mg-IP1827-Ab-1/ GM-Tg-mg-IP1827-Ab-2Anti-Mouse SSR4 monoclonal antibodyMouse
GM-Tg-cynog-IP1827-Ab-1/ GM-Tg-cynog-IP1827-Ab-2Anti-Cynomolgus/ Rhesus macaque SSR4 monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-IP1827-Ab-1/ GM-Tg-felg-IP1827-Ab-2Anti-Feline SSR4 monoclonal antibodyFeline
GM-Tg-cang-IP1827-Ab-1/ GM-Tg-cang-IP1827-Ab-2Anti-Canine SSR4 monoclonal antibodyCanine
GM-Tg-bovg-IP1827-Ab-1/ GM-Tg-bovg-IP1827-Ab-2Anti-Bovine SSR4 monoclonal antibodyBovine
GM-Tg-equg-IP1827-Ab-1/ GM-Tg-equg-IP1827-Ab-2Anti-Equine SSR4 monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-IP1827-Ab-1/ GM-Tg-hg-IP1827-Ab-2; GM-Tg-rg-IP1827-Ab-1/ GM-Tg-rg-IP1827-Ab-2;
GM-Tg-mg-IP1827-Ab-1/ GM-Tg-mg-IP1827-Ab-2; GM-Tg-cynog-IP1827-Ab-1/ GM-Tg-cynog-IP1827-Ab-2;
GM-Tg-felg-IP1827-Ab-1/ GM-Tg-felg-IP1827-Ab-2; GM-Tg-cang-IP1827-Ab-1/ GM-Tg-cang-IP1827-Ab-2;
GM-Tg-bovg-IP1827-Ab-1/ GM-Tg-bovg-IP1827-Ab-2; GM-Tg-equg-IP1827-Ab-1/ GM-Tg-equg-IP1827-Ab-2
Products NameAnti-SSR4 monoclonal antibody
Formatmab
Target NameSSR4
Protein Sub-locationIntrocelluar Protein
Category of antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by ELISA with recombinant soluble protein antigen. The potency in neutralizing, inhibiting or blocking of the target protein is not detected.
TagFc
Products descriptionPre-made anti-SSR4 monoclonal antibody(mab) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenGM-Tg-g-IP1827-Ag-1Recombinant multi-species SSRD/ SSR4/ CDG1Y protein
    ORF Viral VectorpGMLPm003781mouse Ssr4 Lentivirus plasmid
    ORF Viral VectorvGMLPm003781mouse Ssr4 Lentivirus particle


    Target information

    Target IDGM-IP1827
    Target NameSSR4
    Gene ID6748,20832,29435,697266,481082,101081452,504438,100057948
    Gene Symbol and SynonymsCDG1Y,SSR-delta,SSR4,Trap,TRAP-delta,TRAPD
    Uniprot AccessionP51571,Q07984,Q2TBX5
    Uniprot Entry NameSSRD_HUMAN,SSRD_RAT,SSRD_BOVIN
    Protein Sub-locationIntrocelluar Protein
    Category
    DiseaseN/A
    Gene EnsemblENSG00000180879
    Target ClassificationN/A

    The target: SSR4, gene name: SSR4, also named as CDG1Y, TRAPD. This gene encodes the delta subunit of the translocon-associated protein complex which is involved in translocating proteins across the endoplasmic reticulum membrane. The encoded protein is located in the Xq28 region and is arranged in a compact head-to-head manner with the isocitrate dehydrogenase 3 (NAD+) gamma gene and both genes are driven by a CpG-embedded bidirectional promoter. Alternate splicing results in multiple transcript variants.[provided by RefSeq, Mar 2011].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.